BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 30039193)

  • 1. Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.
    Rose S; Niyazov DM; Rossignol DA; Goldenthal M; Kahler SG; Frye RE
    Mol Diagn Ther; 2018 Oct; 22(5):571-593. PubMed ID: 30039193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of mitochondrial dysfunction in autism spectrum disorder: A systematic review and meta-analysis.
    Frye RE; Rincon N; McCarty PJ; Brister D; Scheck AC; Rossignol DA
    Neurobiol Dis; 2024 Jul; 197():106520. PubMed ID: 38703861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments.
    Frye RE
    Semin Pediatr Neurol; 2020 Oct; 35():100829. PubMed ID: 32892956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.
    Frye RE; Melnyk S; Macfabe DF
    Transl Psychiatry; 2013 Jan; 3(1):e220. PubMed ID: 23340503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial function and abnormalities implicated in the pathogenesis of ASD.
    Castora FJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():83-108. PubMed ID: 30599156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.
    Frye RE; Rose S; Slattery J; MacFabe DF
    Microb Ecol Health Dis; 2015; 26():27458. PubMed ID: 25956238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Link between Mitochondrial Dysregulation and Idiopathic Autism Spectrum Disorder (ASD): Alterations in Mitochondrial Respiratory Capacity and Membrane Potential.
    Hassan H; Zakaria F; Makpol S; Karim NA
    Curr Issues Mol Biol; 2021 Dec; 43(3):2238-2252. PubMed ID: 34940131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction in autism.
    Legido A; Jethva R; Goldenthal MJ
    Semin Pediatr Neurol; 2013 Sep; 20(3):163-75. PubMed ID: 24331358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gut Microbiota and Oxidative Stress in Autism Spectrum Disorders (ASD).
    Hu T; Dong Y; He C; Zhao M; He Q
    Oxid Med Cell Longev; 2020; 2020():8396708. PubMed ID: 33062148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox metabolism abnormalities in autistic children associated with mitochondrial disease.
    Frye RE; Delatorre R; Taylor H; Slattery J; Melnyk S; Chowdhury N; James SJ
    Transl Psychiatry; 2013 Jun; 3(6):e273. PubMed ID: 23778583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction and autism: comprehensive genetic analyses of children with autism and mtDNA deletion.
    Varga NÁ; Pentelényi K; Balicza P; Gézsi A; Reményi V; Hársfalvi V; Bencsik R; Illés A; Prekop C; Molnár MJ
    Behav Brain Funct; 2018 Feb; 14(1):4. PubMed ID: 29458409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.
    Rossignol DA; Frye RE
    Mol Psychiatry; 2012 Mar; 17(3):290-314. PubMed ID: 21263444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism.
    Rose S; Bennuri SC; Davis JE; Wynne R; Slattery JC; Tippett M; Delhey L; Melnyk S; Kahler SG; MacFabe DF; Frye RE
    Transl Psychiatry; 2018 Feb; 8(1):42. PubMed ID: 29391397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Mitochondrial Morphology and Function in the BTBR Mouse Model of Autism Is Improved by Two Weeks of Ketogenic Diet.
    Ahn Y; Sabouny R; Villa BR; Yee NC; Mychasiuk R; Uddin GM; Rho JM; Shutt TE
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers.
    Khemakhem AM; Frye RE; El-Ansary A; Al-Ayadhi L; Bacha AB
    Metab Brain Dis; 2017 Dec; 32(6):1983-1997. PubMed ID: 28831647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Biomedical Treatment for Autism Spectrum Disorders.
    Pacheva I; Ivanov I
    Curr Pharm Des; 2019; 25(41):4430-4453. PubMed ID: 31801452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autism, Mitochondria and Polybrominated Diphenyl Ether Exposure.
    Wong S; Giulivi C
    CNS Neurol Disord Drug Targets; 2016; 15(5):614-23. PubMed ID: 27071785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites.
    Mussap M; Noto A; Fanos V
    Expert Rev Mol Diagn; 2016 Aug; 16(8):869-81. PubMed ID: 27310602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder.
    Srikantha P; Mohajeri MH
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine lactate concentration as a non-invasive screener for metabolic abnormalities: Findings in children with autism spectrum disorder and regression.
    Boterberg S; Vantroys E; De Paepe B; Van Coster R; Roeyers H
    PLoS One; 2022; 17(9):e0274310. PubMed ID: 36084111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.